<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00747006</url>
  </required_header>
  <id_info>
    <org_study_id>MKC-TI-119</org_study_id>
    <nct_id>NCT00747006</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Technosphere速 Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake</brief_title>
  <official_title>A Phase 2, Single-Center, Open-Label, Pharmacodynamic Clinical Trial to Evaluate the Effect of Technosphere速 Insulin Inhalation Powder Safety and Efficacy of Technosphere速 Insulin Inhalation Powder (TI Inhalation Powder) Safety and Efficacy of Technosphere速 Insulin Inhalation Powder (TI Inhalation Powder) on Postprandial Glucose Levels in Subjects With Type 1 and Type 2 Diabetes Mellitus Ingesting Meals With Varied Carbohydrate Content</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mannkind Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mannkind Corporation</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if, once a favorable dose of TI Inhalation Powder
      is established for either a type 1 or 2 patient, based on a average diabetic meal, the
      patient's favorable dose can be used safely, regardless of change in meal carbohydrate
      content. Patients were randomly assigned to various carbohydrate loads (0%, 50%, 100%, 150%
      or 200%). The 100% carbohydrate load was determined based upon their standard insulin dose
      for their normal meal.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Business reasons
  </why_stopped>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Time 0 Corrected AUC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breakfast Plasma Glucose Time 0 Corrected AUC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Excursion - Original Protocol (TI Treated Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at lunch</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breakfast Plasma Glucose Excursion - Original Protocol (TI Treated - Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at breakfast</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Excursion - Amendment 1 ( TI Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lunch Plasma Glucose Excursion - Amendment 1 (Humalog Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lunch Plasma Glucose AOC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Area over the plasma glucose - time curve from time 0 (immediately before starting lunch) to 240 minutes after the start of the lunch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breakfast Plasma Glucose AOC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Breakfast area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of breakfast</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</measure>
    <time_frame>0 to 240 minutes</time_frame>
    <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>TI Inhalation Powder (original protocol)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Under the original protocol, subjects with Type 1 and Type 2 diabetes will have TI Inhalation Powder administered prandially during dose optimization visits and meal challenge visits (with meals of varying carbohydrate contents). Subjects with Type 2 diabetes will also use TI Inhalation Powder daily at each meal between visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TI Inhalation Powder and Humalog (Amendment 1)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Under Amendment 1, TI Inhalation Powder will be administered prandially to a new subset of subjects with Type 2 diabetes during TI dose optimization visits and TI meal challenge visits (with meals of varying carbohydrate contents). Subjects will be crossed over to administration of Humalog 15 minutes before meals during Humalog dose optimization visits and Humalog meal challenge visits (with meals of varying carbohydrate contents). Subjects will also use TI Inhalation Powder daily at each meal between visits.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TI Inhalation Powder and Humalog (Amendment 1)</intervention_name>
    <description>Subcutaneous (sc) rapid acting analog to be administered at one half of the meal challenge visits 15 minutes before a meal. Only the last 5 - 10 patients (Type 2) will be undergoing this amendment to the protocol.</description>
    <arm_group_label>TI Inhalation Powder and Humalog (Amendment 1)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TI Inhalation Powder (original protocol)</intervention_name>
    <description>Inhaled insulin technology to be administered immediately before a meal (prandially) for glucose control in Type 1 or Type 2 diabetics</description>
    <arm_group_label>TI Inhalation Powder (original protocol)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnoses of type 1 or type 2 diabetes mellitus

          -  Fasting Plasma Glucose (FPG) 80, 140 mg/dL and glycated hemoglobin (A1C) &gt; 6.5% and &lt;
             or = 10.0%.

          -  Body mass index (BMI) of &lt; or = 40 kg/m2

          -  Non-smokers (never smoked or former smokers [= 6 months since cessation]) and a urine
             cotinine level &lt; or = 100 ng/dL

          -  Forced expiratory volume in 1 second (FEV1) = 70% Third National Health and Nutrition
             Examination Survey (NHANES III) Predicted; pre-bronchodilator FEV1 as a percentage of
             forced vital capacity (FEV1/Forced vital capacity(FVC)) = 70%

          -  For subjects with type 2 diabetes mellitus: Currently receiving oral diabetic
             treatment or basal insulin +/- oral diabetic treatment

        Exclusion Criteria:

          -  History of chronic obstructive pulmonary disease (COPD), clinically proven asthma,
             and/or any other clinically important pulmonary disease confirmed by pulmonary
             function test (PFT) and/or radiologic findings

          -  Elevated liver function test (alanine aminotransferase [ALT] or aspartate
             aminotransferase [AST] &gt; 3 times the normal reference range or bilirubin &gt; 1.5 times
             the reference range)

          -  Previous use of Exubera; use of Symlin (pramlintide acetate) and/or Byetta (exenatide)
             within the past 12 weeks

          -  Unstable diabetes control and evidence of severe complications of diabetes mellitus
             (ie, autonomic neuropathy)

          -  Exposure to any investigational product(s) in the past 12 weeks

          -  For subjects with type 2 diabetes mellitus: In subjects taking metformin, serum
             creatinine &gt; 1.4 mg/dL in female subjects and &gt; 1.5 mg/dL in male subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sansum Medical Research Institute</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2008</study_first_submitted>
  <study_first_submitted_qc>September 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2008</study_first_posted>
  <results_first_submitted>July 22, 2014</results_first_submitted>
  <results_first_submitted_qc>October 20, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 21, 2014</results_first_posted>
  <disposition_first_submitted>June 9, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>October 23, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">October 27, 2009</disposition_first_posted>
  <last_update_submitted>October 21, 2014</last_update_submitted>
  <last_update_submitted_qc>October 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Lispro</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Original Protocol Type 1 Diabetes</title>
          <description>Original protocol participants with Type 1 diabetes given Technosphere Insulin (TI - doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
        <group group_id="P2">
          <title>Original Protocol Type 2 Diabetes</title>
          <description>Original protocol participants with Type 2 diabetes given Technosphere Insulin (TI - doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
        <group group_id="P3">
          <title>Amendment 1 Type 2 Diabetes</title>
          <description>Protocol amendment 1 participants with Type 2 diabetes given humalog (doses individualized for each patient) or Technosphere Insulin (doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Randomized Subjects. Patients were randomly assigned to various carbohydrate loads (0%, 50%, 100%, 150% or 200%). The 100% carbohydrate load was determined based upon their standard insulin dose for their normal meal.</population>
      <group_list>
        <group group_id="B1">
          <title>Original Protocol Type 1 Diabetes</title>
          <description>Original protocol participants with Type 1 diabetes given Technosphere Insulin (TI - doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
        <group group_id="B2">
          <title>Original Protocol Type 2 Diabetes</title>
          <description>Original protocol participants with Type 2 diabetes given Technosphere Insulin (TI - doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
        <group group_id="B3">
          <title>Amendment 1 Type 2 Diabetes</title>
          <description>Protocol amendment 1 participants with Type 2 diabetes given humalog (doses individualized for each patient) or Technosphere Insulin (doses individualized for each patient) at various carbohydrate loads [0%, 50%, 100% (reference), 200%, and if necessary, 150%)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.7" lower_limit="18" upper_limit="54"/>
                    <measurement group_id="B2" value="59.4" lower_limit="50" upper_limit="70"/>
                    <measurement group_id="B3" value="50.7" lower_limit="48" upper_limit="52"/>
                    <measurement group_id="B4" value="50.7" lower_limit="18" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Time 0 Corrected AUC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
        <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Time 0 Corrected AUC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
          <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-41.44" lower_limit="-43.44" upper_limit="-39.43"/>
                    <measurement group_id="O4" value="251.65" lower_limit="24.08" upper_limit="490.63"/>
                    <measurement group_id="O5" value="454.07" lower_limit="329.64" upper_limit="636.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Breakfast Plasma Glucose Time 0 Corrected AUC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
        <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Breakfast Plasma Glucose Time 0 Corrected AUC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
          <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.32" lower_limit="14.50" upper_limit="194.13"/>
                    <measurement group_id="O3" value="10.80" lower_limit="-44.86" upper_limit="98.50"/>
                    <measurement group_id="O4" value="199.35" lower_limit="116.70" upper_limit="282.00"/>
                    <measurement group_id="O5" value="440.90" lower_limit="269.18" upper_limit="583.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</title>
        <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Technosphere Insulin Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</title>
          <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Technosphere Insulin Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.11" lower_limit="-22.63" upper_limit="10.41"/>
                    <measurement group_id="O2" value="-74.26" lower_limit="-99.88" upper_limit="-48.63"/>
                    <measurement group_id="O3" value="-22.80" lower_limit="-22.80" upper_limit="-22.80"/>
                    <measurement group_id="O5" value="11.56" lower_limit="-2.36" upper_limit="25.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
        <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Time 0 Corrected AUC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
          <description>AUC (area under the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is above time 0 value.
AOC (area over the plasma glucose - time curve) from time 0 (immediately before starting meal) to 240 minutes after the start of the meal when the curve is below time 0 value.
TIme 0 corrected AUC (0-240) = AUC - AOC</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.77" lower_limit="9.48" upper_limit="22.06"/>
                    <measurement group_id="O2" value="-51.26" lower_limit="-89.13" upper_limit="-13.38"/>
                    <measurement group_id="O3" value="4.18" lower_limit="-15.39" upper_limit="23.75"/>
                    <measurement group_id="O5" value="-8.15" lower_limit="-68.76" upper_limit="52.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Excursion - Original Protocol (TI Treated Type 1 Subjects)</title>
        <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Excursion - Original Protocol (TI Treated Type 1 Subjects)</title>
          <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at lunch</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.00" lower_limit="42.00" upper_limit="66.00"/>
                    <measurement group_id="O4" value="129.67" lower_limit="75.00" upper_limit="210.00"/>
                    <measurement group_id="O5" value="201.00" lower_limit="163.00" upper_limit="231.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Breakfast Plasma Glucose Excursion - Original Protocol (TI Treated - Type 1 Subjects)</title>
        <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at breakfast</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Breakfast Plasma Glucose Excursion - Original Protocol (TI Treated - Type 1 Subjects)</title>
          <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax - Cmin) at breakfast</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.50" lower_limit="43.00" upper_limit="64.00"/>
                    <measurement group_id="O3" value="44.33" lower_limit="42.00" upper_limit="48.00"/>
                    <measurement group_id="O4" value="89.50" lower_limit="78.00" upper_limit="101.00"/>
                    <measurement group_id="O5" value="186.33" lower_limit="134.00" upper_limit="234.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Excursion - Amendment 1 ( TI Treated Type 2 Subjects)</title>
        <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus TI Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Excursion - Amendment 1 ( TI Treated Type 2 Subjects)</title>
          <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus TI Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.50" lower_limit="26.00" upper_limit="33.00"/>
                    <measurement group_id="O2" value="14.50" lower_limit="13.00" upper_limit="16.00"/>
                    <measurement group_id="O3" value="16.00" lower_limit="16.00" upper_limit="16.00"/>
                    <measurement group_id="O5" value="18.50" lower_limit="17.00" upper_limit="20.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lunch Plasma Glucose Excursion - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
        <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose Excursion - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
          <description>Excursion is the difference between plasma glucose Cmax and Cmin (Cmax-Cmin) at lunch</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.50" lower_limit="44.00" upper_limit="45.00"/>
                    <measurement group_id="O2" value="20.00" lower_limit="9.00" upper_limit="31.00"/>
                    <measurement group_id="O3" value="23.50" lower_limit="11.00" upper_limit="36.00"/>
                    <measurement group_id="O5" value="45.50" lower_limit="35.00" upper_limit="56.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lunch Plasma Glucose AOC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
        <description>Area over the plasma glucose - time curve from time 0 (immediately before starting lunch) to 240 minutes after the start of the lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose AOC (0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
          <description>Area over the plasma glucose - time curve from time 0 (immediately before starting lunch) to 240 minutes after the start of the lunch</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 50% carbohydrate load was administered but not completed due to all subjects having hypoglycemia, 0% carbohydrate load was deemed unsafe by PI</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.89" lower_limit="47.61" upper_limit="60.16"/>
                    <measurement group_id="O4" value="19.16" lower_limit="0.00" upper_limit="57.49"/>
                    <measurement group_id="O5" value="8.77" lower_limit="0.00" upper_limit="26.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Breakfast Plasma Glucose AOC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
        <description>Breakfast area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of breakfast</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Breakfast Plasma Glucose AOC(0-240) - Original Protocol (TI Treated Type 1 Subjects)</title>
          <description>Breakfast area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of breakfast</description>
          <population>Original Protocol Type 1 Diabetes Mellitus Technosphere Insulin Treated; 0% carbohydrate load was deemed unsafe by PI</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.25" lower_limit="0.00" upper_limit="20.50"/>
                    <measurement group_id="O3" value="30.45" lower_limit="0.00" upper_limit="59.00"/>
                    <measurement group_id="O4" value="6.30" lower_limit="0.00" upper_limit="12.60"/>
                    <measurement group_id="O5" value="3.18" lower_limit="0.00" upper_limit="9.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</title>
        <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Technosphere Insulin Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (TI Treated Type 2 Subjects)</title>
          <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Technosphere Insulin Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.00" lower_limit="5.36" upper_limit="30.63"/>
                    <measurement group_id="O2" value="74.26" lower_limit="48.63" upper_limit="99.88"/>
                    <measurement group_id="O3" value="24.04" lower_limit="24.04" upper_limit="24.04"/>
                    <measurement group_id="O5" value="5.65" lower_limit="1.53" upper_limit="9.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
        <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
        <time_frame>0 to 240 minutes</time_frame>
        <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
        <group_list>
          <group group_id="O1">
            <title>100% Carbohydrate Load</title>
            <description>Standard meal to which subjects titrated their insulin dose.</description>
          </group>
          <group group_id="O2">
            <title>0% Carbohydrate Load</title>
            <description>Fasting state</description>
          </group>
          <group group_id="O3">
            <title>50% Carbohydrate Load</title>
            <description>Meal consisting of half of the carbohydrates from the standard meal</description>
          </group>
          <group group_id="O4">
            <title>150% Carbohydrate Load</title>
            <description>Meal consisting of 1.5 times the carbohydrate load of the standard meal.</description>
          </group>
          <group group_id="O5">
            <title>200% Carbohydrate Load</title>
            <description>Meal consisting of 2 times the carbohydrate load of the standard meal.</description>
          </group>
        </group_list>
        <measure>
          <title>Lunch Plasma Glucose AOC(0-240) - Amendment 1 (Humalog Treated Type 2 Subjects)</title>
          <description>Lunch area over the plasma glucose - time curve from time 0 (immediately before breakfast) to 240 minutes after start of lunch</description>
          <population>Protocol Amendment 1 Type 2 Diabetes Mellitus Humalog Treated Subjects; 150% carbohydrate load was not done per protocol since the 200% carbohydrate load was administered</population>
          <units>min*mg/dL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.60" lower_limit="11.34" upper_limit="17.86"/>
                    <measurement group_id="O2" value="51.63" lower_limit="14.13" upper_limit="89.13"/>
                    <measurement group_id="O3" value="12.52" lower_limit="7.50" upper_limit="17.53"/>
                    <measurement group_id="O5" value="40.84" lower_limit="10.89" upper_limit="70.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>TI Original Protocol Type 1 DM</title>
          <description>Original protocol type 1 diabetes mellitus subjects</description>
        </group>
        <group group_id="E2">
          <title>TI Original Protocol Type 2 DM</title>
          <description>Original protocol type 2 diabetes mellitus subjects</description>
        </group>
        <group group_id="E3">
          <title>TI Amendment 1 Type 2 DM</title>
          <description>Technosphere Insulin treated subjects in protocol amendment 1</description>
        </group>
        <group group_id="E4">
          <title>Humalog Amendment 1 Type 2 DM</title>
          <description>Humalog treated subjects in protocol amendment 1</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 7.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal papillary necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (7.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Venipuncture site thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to plants</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Forced expiratory volume decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Platelet count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Snoring</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>- Early termination of trial leading to small numbers of subjects analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Chief Medical Officer</name_or_title>
      <organization>MannKind Corporation</organization>
      <phone>201-983-5000</phone>
      <email>aboss@mannkindcorp.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

